PLTR
PLTR: Moore Alexander D. discloses a sale
Moore Alexander D. reported Sale in Palantir Technologies Inc.: 600 units of Class A Common Stock, dated 2026-10-15. The full Form 4 contains 8 transaction entries.
PLTR
Moore Alexander D. reported Sale in Palantir Technologies Inc.: 600 units of Class A Common Stock, dated 2026-10-15. The full Form 4 contains 8 transaction entries.
RSG
Vander Ark Jon reported Grant or award in REPUBLIC SERVICES, INC.: 131.52 units of Restricted Stock Units (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
LPTH
Miranda Albert reported Grant or award in LIGHTPATH TECHNOLOGIES INC: 75000 units of Stock Option (Right to Buy) (derivative), dated 2026-03-23. The full Form 4 contains 1 transaction entry.
ORCL
Sicilia Michael D. reported Grant or award in ORACLE CORP: 446197 units of Restricted Stock Unit (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
RSG
Craig Ian M. reported Grant or award in REPUBLIC SERVICES, INC.: 2.7 units of Restricted Stock Units (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
RSG
Duffy Michael A reported Grant or award in REPUBLIC SERVICES, INC.: 29.29 units of Restricted Stock Units (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
RSG
HANDLEY THOMAS W reported Grant or award in REPUBLIC SERVICES, INC.: 72.71 units of Restricted Stock Units (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
EXOZ
BELL LON E reported Grant or award in EXOZYMES INC.: 10000 units of Stock Option (right to buy) (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
RSG
Kadre Manuel reported Grant or award in REPUBLIC SERVICES, INC.: 117.47 units of Restricted Stock Units (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
IAM
Rachlin Evan Lockwood reported Conversion in Iambic Therapeutics, Inc.: 1458736 units of Common Stock, dated 2026-10-16. The full Form 4 contains 8 transaction entries.
EXOZ
Lalonde James Joseph reported Grant or award in EXOZYMES INC.: 10000 units of Stock Option (right to buy) (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
IAM
RASTETTER WILLIAM H reported Conversion in Iambic Therapeutics, Inc.: 192579 units of Common Stock, dated 2026-10-16. The full Form 4 contains 7 transaction entries.
RSG
Kirk Jennifer M reported Grant or award in REPUBLIC SERVICES, INC.: 72.71 units of Restricted Stock Units (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
IAM
Secora Michael reported Conversion in Iambic Therapeutics, Inc.: 61342 units of Common Stock, dated 2026-10-16. The full Form 4 contains 2 transaction entries.
RSG
LARSON MICHAEL reported Grant or award in REPUBLIC SERVICES, INC.: 115.64 units of Restricted Stock Units (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
IAM
Vogelstein R Jacob reported Conversion in Iambic Therapeutics, Inc.: 1995749 units of Common Stock, dated 2026-10-16. The full Form 4 contains 8 transaction entries.
ORCL
ELLISON LAWRENCE JOSEPH reported Grant or award in ORACLE CORP: 223099 units of Restricted Stock Unit (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
ORCL
HENLEY JEFFREY reported Grant or award in ORACLE CORP: 66930 units of Restricted Stock Unit (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
ORCL
Hura Mark reported Grant or award in ORACLE CORP: 237972 units of Restricted Stock Unit (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
ORCL
Levey Stuart reported Grant or award in ORACLE CORP: 104113 units of Restricted Stock Unit (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
ORCL
Magouyrk Clayton M. reported Grant or award in ORACLE CORP: 446197 units of Restricted Stock Unit (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
BLLN
Lynch Thomas P. reported Exercise or conversion in BillionToOne, Inc.: 2000 units of Class A Common Stock, dated 2026-10-13. The full Form 4 contains 2 transaction entries.
ORCL
Maxson Hilary B reported Grant or award in ORACLE CORP: 89240 units of Restricted Stock Unit (derivative), dated 2026-10-15. The full Form 4 contains 1 transaction entry.
LPTH
Rubin Shmuel reported Grant or award in LIGHTPATH TECHNOLOGIES INC: 375000 units of Restricted Stock Units (derivative), dated 2026-03-23. The full Form 4 contains 1 transaction entry.